Navigation Links
Large-Scale Global Registry to Examine Treatment Patterns and Disease Burden Among Patients with Venous Thromboembolism (VTE)
Date:9/3/2013

AMSTERDAM, Sept. 3, 2013 /PRNewswire/ -- The Thrombosis Research Institute (TRI) today announced the launch of the GARFIELD (Global Anticoagulant Registry in the FIELD) VTE Registry, an innovative research initiative exploring acute and long-term management and outcomes in patients with symptomatic venous thromboembolism (VTE).  Led by an international steering committee under the auspices of the TRI, the registry will follow 10,000 patients with acute VTE in a real-world setting.  GARFIELD VTE is supported by an unrestricted research grant from Bayer HealthCare.

VTE is a disease process that encompasses two interrelated conditions: deep vein thrombosis (DVT), in which a blood clot forms in a deep vein such as the legs, and pulmonary embolism (PE), a life-threatening condition in which part of the clot breaks off and is carried to the lungs through the heart, cutting off the flow of blood to the lungs.  In the Western world, one person dies every 37 seconds from VTE.

"Venous thromboembolism continues to represent an important clinical challenge, with a heavy burden for patients and healthcare systems," said Professor The Lord Kakkar, Professor of Surgery at University College London and Director of the Thrombosis Research Institute, London, UK. "Better understanding how best patient outcomes can be achieved will be greatly assisted through robust outcomes research.  We are grateful for the unrestricted grant from Bayer Healthcare to support the Garfield VTE Registry which builds on our experience in better understanding the real world challenges of providing anticoagulation to prevent thromboembolic stroke in the Garfield AF Registry."

About GARFIELD
GARFIELD is a pioneering outcomes research initiative led under the auspices of the TRI through an unrestricted research grant from Bayer HealthCare.  It is comprised of two large-scale registries: '/>"/>

SOURCE Thrombosis Research Institute
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Large-Scale Kaiser Permanente Program Linked to Improved Blood Pressure Control
2. First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams
3. First Large-Scale Population-Based Study in the U.S. Shows Hologics 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
4. Large-Scale Meta-Analysis Shows Age Not a Social Barrier to Opioid Use and Misuse
5. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
6. DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference
7. PharmAthene to Present at Rodman & Renshaw Annual Global Investment Conference
8. Peripheral Vascular Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
9. Philips launches new EPIQ premium ultrasound system with first-of-its-kind nSIGHT technology and Anatomical Intelligence, to address complicated imaging needs of an aging global population
10. MEMS in Medical Applications Market is Expected to Reach USD 6.5 Billion Globally in 2019: Transparency Market Research
11. Injectable Dose Formulations Highly Impact Global Pharmaceutical Contract Manufacturing Vendor Revenues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 30, 2015 ... the addition of the "Biomedical Photoacoustic ... offering. This patent landscape focuses ... is a safe, non-invasive, non-ionizing imaging technique. ... a great alternative to traditional medical imaging ...
(Date:7/7/2015)... , July 7, 2015 A power morcellator ... has been settled for an undisclosed amount, Bernstein Liebhard ... filed in March 2014 in the U.S. District Court, ... behalf of a widower whose wife had died in ... a hysterectomy that involved the use of a power ...
(Date:7/7/2015)... California , 7 de julio de 2015 ... médicos de propiedad privada centrada en el desarrollo ... enfermedad neurovascular, ha anunciado hoy que R. ... junta directiva. Kleine cuenta con ... industrias de los dispositivos médicos y la sanidad. ...
Breaking Medicine Technology:Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 2Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 3Sequent Medical nombra a Mike Kleine a su junta directiva 2Sequent Medical nombra a Mike Kleine a su junta directiva 3
... VILLAGE, Colo., Jan. 5, 2012 Ampio Pharmaceuticals, Inc. (NASDAQ: ... company that discovers and develops new uses for previously approved ... will hold a Web Cast on Thursday, January 26, 2012 ... to update our shareholders on the company,s progress and a ...
... AMRI ), a global contract services organization, announced ... agreement with BioPontis Alliance LLC. The agreement is aimed ... early-stage research and technologies being discovered and developed in ... services in small molecule discovery, development, and manufacturing in ...
Cached Medicine Technology:Ampio Pharmaceuticals Schedules Webcast to Update Shareholders 2Ampio Pharmaceuticals Schedules Webcast to Update Shareholders 3AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC 2AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC 3
(Date:7/7/2015)... ... ... Quadrino Law Group is pleased to announce the relocation of the firm's headquarters ... facility is a state of the art building, located with easy access to New ... founder, said, "We are pleased to service our clients from such a premier location ...
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois ... board is limited to permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) ... industry forward and are committed to making sure patients have access to cannabis ...
(Date:7/7/2015)... ... July 07, 2015 , ... SC&H Group, a leading ... aims to give back to the community through company-wide volunteering efforts. , On an ... dedicate the day to assisting those in need throughout Baltimore and Washington D.C. ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, ... Inc. to access its antibody combination therapy (ACT) technology platform. The platform ...
(Date:7/7/2015)... ... ... end of June Pacific Prime Renewals team in Hong Kong announced that they were ... Manager, Danielle Cotton, aims to not only reduce but eventually eliminate the use of paper ... anything between 300 and 600 pieces of paper per month. Not to mention A4 sized ...
Breaking Medicine News(10 mins):Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2
... virus in people, researchers say , FRIDAY, Jan. 22 ... a commonly used drug combination might protect people from ... routes of transmission. , Previous research showed that the ... medication prevented HIV infection through anal sex and intravenously. ...
... important than method, study says , FRIDAY, Jan. 22 (HealthDay News) ... the best time to start potty training may be between the ... 32 months is the ideal window for moving your child out ... more likely to have urge incontinence -- daytime wetting and bed-wetting ...
... reduce harm to mother and baby, researchers say , ... depression, lack of social support and unintended pregnancy are ... of depression in pregnant women, a new study shows. ... and having public insurance coverage, said the University of ...
... known that having a conversation (for example on a cell ... is also true: Driving reduces one,s ability to comprehend and ... of Illinois, appear in the journal Psychonomic Bulletin & ... that driving impairs language skills, said Gary Dell, a psycholinguist ...
... drug fampridine-SR for the treatment of multiple sclerosis. Researchers ... evaluating the effects of the drug in MS for more ... enhance some neurological functions in people with the disease ... by the FDA. "This is a good ...
... team of scientists led by Professor Adrian Krainer, Ph.D., ... in cancer cells that boost the production of an ... The altered metabolic state, called the Warburg effect, promotes ... Discovered eighty years ago by Nobel Prize-winning scientist ...
Cached Medicine News:Health News:Drug Combo Blocks HIV Infection in Mice 2Health News: Potty Training Best Between Ages 2 and 3 2Health News: Potty Training Best Between Ages 2 and 3 3Health News: Potty Training Best Between Ages 2 and 3 4Health News:Driven to distraction: New study shows driving hinders talking 2Health News:Researchers welcome new multiple sclerosis drug 2Health News:Researchers welcome new multiple sclerosis drug 3Health News:CSHL study identifies potential way to reverse cancer cell metabolism and tumor growth 2Health News:CSHL study identifies potential way to reverse cancer cell metabolism and tumor growth 3
The IntraStent DoubleStrut Biliary Stent represents a completely new direction in stent design. The combination of parallel struts and unique cell geometry provide unparalleled performance....
The Smart Check Syphilis Device is a qualitative membrane device based immunoassay for the detection of TP (Treponema Pallidum) antibodies in whole blood/serum/plasma. For professional in vitro diagn...
Bio-Quant, Inc. OneStep hCG InstaTest is an immunochromatographic assay designed for qualitative determination of human chorionic gonadotropin (hCG) in urine for early detection of pregnancy....
OneStep Midstream Urine hCG Pregnancy InstaTest is a test kit for the determination of hCG(Human Chorionic Gonadotropin) in urine specimens. This test kit is used to obtain a visual, qualitative resu...
Medicine Products: